Harm Reduction Therapeutics
  • About
  • Naloxone
  • Resources
  • News
  • Contact
Select Page
HRT CEO Dr. Hufford presents at the FDA’s Advisory Committee Meeting on the Availability Naloxone

HRT CEO Dr. Hufford presents at the FDA’s Advisory Committee Meeting on the Availability Naloxone

by Brian Shim | Dec 18, 2018 | News

The costs of heroin and naloxone: a tragic snapshot of the opioid crisis

The costs of heroin and naloxone: a tragic snapshot of the opioid crisis

by Brian Shim | Nov 8, 2018 | News

Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Work to Develop Inexpensive, Over-the-Counter, Life-Saving Naloxone in the United States

Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Work to Develop Inexpensive, Over-the-Counter, Life-Saving Naloxone in the United States

by Brian Shim | Sep 5, 2018 | News

HRT CEO Dr. Hufford presents at the Nicholas Hall Conference

HRT CEO Dr. Hufford presents at the Nicholas Hall Conference

by Brian Shim | Jul 5, 2018 | News

HRT receives a $3.42M grant from Purdue Pharma

HRT receives a $3.42M grant from Purdue Pharma

by Brian Shim | Jul 5, 2018 | News

« Older Entries
Next Entries »

About

Harm Reduction Therapeutics (HRT), Inc. is a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making free or low-cost over-the-counter naloxone available to everyone. Founded in 2017 in response to the severe price and access limits to existing naloxone products, HRT brings together experts in drug development, harm reduction, substance dependence, public health policy, and over-the-counter switches of prescription pharmaceuticals.

Social

  • Twitter
  • Instagram

Useful Links

  • Home
  • About
  • Naloxone
  • Resources
  • News
  • Contact
© Copyright 2022 Harm Reduction Therapeutics. All Rights Reserved. Privacy. Accessibility.